Memantine hydrochloride 5mg orally disintegrating tablets (YJ code: 1190018F4014, standard: 5mg 1 tablet) is a generic formulation containing memantine hydrochloride. This NMDA receptor antagonist is used to treat moderate to severe Alzheimer’s disease by regulating abnormal brain activity to improve cognitive function.
Memantine hydrochloride 5mg orally disintegrating tablets
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
More with the same ingredient
